ASX - By Stock
|
OSX |
Re:
Osteopore Discussion
|
|
Migy119
|
13 |
3.1K |
0 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
13
|
3.1K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Quotation
|
|
Migy119
|
15 |
5.5K |
0 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
15
|
5.5K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore secures Singapore and Vietnam market approvals
|
|
Migy119
|
49 |
20K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
49
|
20K
|
3
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
Migy119
|
45 |
16K |
0 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
45
|
16K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
Migy119
|
45 |
16K |
3 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
45
|
16K
|
3
|
|
ASX - By Stock
|
OSX |
Re:
Ann: OSX achieves 100k implants, to accelerate commercialisation
|
|
Migy119
|
4 |
1.4K |
0 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
4
|
1.4K
|
0
|
|
ASX - By Stock
|
PLL |
Re:
PLL General Discussion
|
|
Migy119
|
2.4K |
804K |
7 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
2.4K
|
804K
|
7
|
|
ASX - By Stock
|
KAR |
Re:
Ann: Successful bid for blocks in Santos Basin
|
|
Migy119
|
8 |
3.8K |
3 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
8
|
3.8K
|
3
|
|
ASX - By Stock
|
MLS |
Re:
MLS Andover Covette Lithium potential .
|
|
Migy119
|
308 |
76K |
2 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
308
|
76K
|
2
|
|
ASX - By Stock
|
MLS |
Re:
MLS Andover Covette Lithium potential .
|
|
Migy119
|
308 |
76K |
5 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
308
|
76K
|
5
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Activities Update Qtr Ending September 2023 and Appendix 4C
|
|
Migy119
|
13 |
4.7K |
1 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
13
|
4.7K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Activities Update Qtr Ending September 2023 and Appendix 4C
|
|
Migy119
|
13 |
4.7K |
2 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
13
|
4.7K
|
2
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Activities Update Qtr Ending September 2023 and Appendix 4C
|
|
Migy119
|
13 |
4.7K |
2 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
13
|
4.7K
|
2
|
|
ASX - By Stock
|
OSX |
Re:
Ann: MOU with Temasek-linked Innoventures - Orthopaedics in China
|
|
Migy119
|
33 |
8.1K |
0 |
27/10/23 |
27/10/23 |
ASX - By Stock
|
33
|
8.1K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: MOU with Temasek-linked Innoventures - Orthopaedics in China
|
|
Migy119
|
33 |
8.1K |
0 |
28/09/23 |
28/09/23 |
ASX - By Stock
|
33
|
8.1K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: MOU with Temasek-linked Innoventures - Orthopaedics in China
|
|
Migy119
|
33 |
8.1K |
2 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
33
|
8.1K
|
2
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Investor Presentation
|
|
Migy119
|
64 |
14K |
0 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
64
|
14K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Activities Update Qtr Ending June 2023 and Appendix 4C
|
|
Migy119
|
25 |
4.5K |
1 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
25
|
4.5K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Clarification Announcement
|
|
Migy119
|
13 |
2.1K |
1 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
13
|
2.1K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Activities Update Qtr Ending June 2023 and Appendix 4C
|
|
Migy119
|
25 |
4.5K |
2 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
25
|
4.5K
|
2
|
|
ASX - By Stock
|
OSX |
Re:
Ann: OSX receives A$10m commitment for commercialisation in China
|
|
Migy119
|
56 |
9.5K |
1 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
56
|
9.5K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: OSX receives A$10m commitment for commercialisation in China
|
|
Migy119
|
56 |
9.5K |
1 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
56
|
9.5K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Notice of Breach of ASX Listing Rule 10.11
|
|
Migy119
|
6 |
1.7K |
1 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
6
|
1.7K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Notice of Breach of ASX Listing Rule 10.11
|
|
Migy119
|
6 |
1.7K |
1 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
6
|
1.7K
|
1
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Strategic Partnership for Clinical R&D in China worth $4M
|
|
Migy119
|
20 |
8.0K |
2 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
20
|
8.0K
|
2
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Strategic Partnership for Clinical R&D in China worth $4M
|
|
Migy119
|
20 |
8.0K |
4 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
20
|
8.0K
|
4
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Activities Update Qtr Ending March 2023 and Appendix 4C
|
|
Migy119
|
13 |
3.8K |
3 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
13
|
3.8K
|
3
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Non-Renounceable Entitlement Offer - Results
|
|
Migy119
|
10 |
2.3K |
0 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
10
|
2.3K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Activities Update Qtr Ending December 2022 and Appendix 4C
|
|
Migy119
|
8 |
2.9K |
2 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
8
|
2.9K
|
2
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Firm Commitments and Non-Binding Proposed Acquisition
|
|
Migy119
|
6 |
3.2K |
3 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
6
|
3.2K
|
3
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Firm Commitments and Non-Binding Proposed Acquisition
|
|
Migy119
|
6 |
3.2K |
0 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
6
|
3.2K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Suspension from Official Quotation
|
|
Migy119
|
2 |
807 |
0 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
2
|
807
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore secures A$19m clinical-industrial partnership
|
|
Migy119
|
4 |
2.3K |
2 |
13/12/21 |
13/12/21 |
ASX - By Stock
|
4
|
2.3K
|
2
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Activities Update Qtr Ending September 2021 and Appendix 4C
|
|
Migy119
|
9 |
2.8K |
0 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
9
|
2.8K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Trading Halt
|
|
Migy119
|
16 |
6.1K |
4 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
16
|
6.1K
|
4
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Trading Halt
|
|
Migy119
|
16 |
6.1K |
0 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
16
|
6.1K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore Signs Initial U.S. Distribution Agreement
|
|
Migy119
|
45 |
15K |
6 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
45
|
15K
|
6
|
|
ASX - By Stock
|
OSX |
Not much happening
|
|
Migy119
|
5 |
1.8K |
0 |
24/06/20 |
24/06/20 |
ASX - By Stock
|
5
|
1.8K
|
0
|
|
ASX - By Stock
|
COH |
Re:
Ann: UK cochlear implant criteria change
|
|
Migy119
|
5 |
5.7K |
1 |
12/03/19 |
12/03/19 |
ASX - By Stock
|
5
|
5.7K
|
1
|
|
ASX - By Stock
|
COH |
Re:
Ann: UK cochlear implant criteria change
|
|
Migy119
|
5 |
5.7K |
0 |
08/03/19 |
08/03/19 |
ASX - By Stock
|
5
|
5.7K
|
0
|
|
ASX - By Stock
|
COH |
Re:
Ann: UK cochlear implant criteria change
|
|
Migy119
|
5 |
5.7K |
2 |
08/03/19 |
08/03/19 |
ASX - By Stock
|
5
|
5.7K
|
2
|
|